{"id":1196,"date":"2018-11-10T23:06:48","date_gmt":"2018-11-10T23:06:48","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=1196"},"modified":"2026-02-24T15:35:52","modified_gmt":"2026-02-24T15:35:52","slug":"constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2018\/11\/10\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\/","title":{"rendered":"Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy (Contributed by Manon Suerink and Dr. Katharina Wimmer)"},"content":{"rendered":"

Constitutional mismatch repair deficiency (CMMRD) is a very rare genetic condition conferring an extraordinarily high risk for development of cancer already during childhood and young adulthood. Patients with this cancer syndrome frequently have multiple caf\u00e9-au-lait spots and other signs that are indicative of a different, much more common condition, which is neurofibromatosis type 1 (NF1) caused by mutations in the NF1 gene. Recognising CMMRD in a child on the basis of NF1 features before cancer has developed provides the opportunity to start cancer surveillance early on. We developed guidelines that recommend when children suspected of NF1 but without an NF1 mutation should be tested for CMMRD.\u00a0 (https:\/\/jmg.bmj.com\/content\/early\/2018\/11\/10\/jmedgenet-2018-105664<\/a> )<\/p>\n","protected":false},"excerpt":{"rendered":"

Constitutional mismatch repair deficiency (CMMRD) is a very rare genetic condition conferring an extraordinarily high risk for development of cancer already during childhood and young adulthood. Patients with this cancer syndrome frequently have multiple caf\u00e9-au-lait spots and other signs that are indicative of a different, much more common condition, which is neurofibromatosis type 1 (NF1) […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1196","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nConstitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy (Contributed by Manon Suerink and Dr. Katharina Wimmer) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2018\/11\/10\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy (Contributed by Manon Suerink and Dr. Katharina Wimmer) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"Constitutional mismatch repair deficiency (CMMRD) is a very rare genetic condition conferring an extraordinarily high risk for development of cancer already during childhood and young adulthood. Patients with this cancer syndrome frequently have multiple caf\u00e9-au-lait spots and other signs that are indicative of a different, much more common condition, which is neurofibromatosis type 1 (NF1) [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2018\/11\/10\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2018-11-10T23:06:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T15:35:52+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/11\\\/10\\\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/11\\\/10\\\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy (Contributed by Manon Suerink and Dr. Katharina Wimmer)\",\"datePublished\":\"2018-11-10T23:06:48+00:00\",\"dateModified\":\"2026-02-24T15:35:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/11\\\/10\\\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\\\/\"},\"wordCount\":141,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/11\\\/10\\\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/11\\\/10\\\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/11\\\/10\\\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\\\/\",\"name\":\"Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy (Contributed by Manon Suerink and Dr. Katharina Wimmer) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2018-11-10T23:06:48+00:00\",\"dateModified\":\"2026-02-24T15:35:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/11\\\/10\\\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/11\\\/10\\\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/11\\\/10\\\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy (Contributed by Manon Suerink and Dr. Katharina Wimmer)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy (Contributed by Manon Suerink and Dr. Katharina Wimmer) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2018\/11\/10\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\/","og_locale":"en_US","og_type":"article","og_title":"Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy (Contributed by Manon Suerink and Dr. Katharina Wimmer) - JMG Contact blog","og_description":"Constitutional mismatch repair deficiency (CMMRD) is a very rare genetic condition conferring an extraordinarily high risk for development of cancer already during childhood and young adulthood. Patients with this cancer syndrome frequently have multiple caf\u00e9-au-lait spots and other signs that are indicative of a different, much more common condition, which is neurofibromatosis type 1 (NF1) [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2018\/11\/10\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\/","og_site_name":"JMG Contact blog","article_published_time":"2018-11-10T23:06:48+00:00","article_modified_time":"2026-02-24T15:35:52+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/11\/10\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/11\/10\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy (Contributed by Manon Suerink and Dr. Katharina Wimmer)","datePublished":"2018-11-10T23:06:48+00:00","dateModified":"2026-02-24T15:35:52+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/11\/10\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\/"},"wordCount":141,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2018\/11\/10\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/11\/10\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\/","url":"https:\/\/blogs.bmj.com\/jmg\/2018\/11\/10\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\/","name":"Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy (Contributed by Manon Suerink and Dr. Katharina Wimmer) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2018-11-10T23:06:48+00:00","dateModified":"2026-02-24T15:35:52+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/11\/10\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2018\/11\/10\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/11\/10\/constitutional-mismatch-repair-deficiency-as-a-differential-diagnosis-of-neurofibromatosis-type-1-consensus-guidelines-for-testing-a-child-without-malignancy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy (Contributed by Manon Suerink and Dr. Katharina Wimmer)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1196","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=1196"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1196\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=1196"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=1196"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=1196"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}